A comparison of daunorubicin/ clofarabine and flag-ida in high risk acute myeloid leukaemia: results from the UK NCRI AML17 trial.
Burnett, A ; Russell, N ; Kjeldsen, L ; Milligan, D ; Hunter, A ; Clark, R ; Dennis, Michael ; Hills, R
Burnett, A
Russell, N
Kjeldsen, L
Milligan, D
Hunter, A
Clark, R
Dennis, Michael
Hills, R
Citations
Altmetric:
Abstract
Affiliation
Description
Date
2015
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
A comparison of daunorubicin/ clofarabine and flag-ida in high risk acute myeloid leukaemia: results from the UK NCRI AML17 trial.. 2015, 100: 39-40 Haematologica